America Great Health Reports 34% Revenue Increase but Faces Net Loss and Shareholders' Deficit

America Great Health reported its financial results for the three months ending September 30, 2025, revealing a revenue increase to $187,559, up from $140,126 in the same period last year. This 34% rise in sales was attributed to two significant wholesale orders linked to the launch of new products. However, the cost of goods sold also surged to $74,880 from $11,335, leading to a gross profit decline to $112,679 compared to $128,791 in the prior year. The company recorded a net loss of $85,363, a decrease from the $146,967 loss reported in the same quarter of 2024, indicating improved operational efficiency despite rising costs.

In terms of operational metrics, America Great Health's total assets decreased to $241,296 as of September 30, 2025, down from $301,817 at the end of June 2025. The company's current liabilities slightly decreased to $3,779,008 from $3,820,947, while total liabilities remained relatively stable at $6,070,405. The shareholders' deficit increased to $5,829,109, reflecting ongoing challenges in achieving profitability. The company’s cash position also weakened, ending the quarter with $28,079 compared to $44,056 at the end of the previous quarter.

Strategically, America Great Health has been focusing on expanding its product offerings and market presence. The company has been developing new health-related products, which contributed to the recent sales increase. However, the launch of these products has also led to higher costs, impacting gross margins. The company continues to explore opportunities for geographic expansion, particularly in Asia, where it generated 97% of its revenue for the quarter. The company’s operational structure includes several subsidiaries, including those focused on biotechnology and health products, which are expected to play a crucial role in future growth.

Looking ahead, America Great Health faces significant challenges, including a substantial shareholders' deficit and ongoing net losses. The company has indicated that it will need to secure additional capital to support its operations and achieve profitability. Management has expressed a commitment to improving financial performance through strategic initiatives and operational efficiencies. However, the ability to raise necessary funds and successfully implement its business plans remains uncertain, as highlighted by the company's going concern status. The management's forward-looking statements emphasize the need for careful monitoring of market conditions and operational performance to navigate these challenges effectively.